Sleep disorders represent a significant and growing public health concern, affecting millions worldwide with substantial impacts on quality of life, cognitive function, and long-term health outcomes. This theme issue brings together contemporary research spanning the spectrum of sleep medicine, from novel pharmacological interventions to clinical management strategies.

The collection explores cutting-edge developments including orexin receptor antagonists as emerging therapeutics for insomnia, the paradoxical benefits of benzodiazepine discontinuation, innovative interventional approaches through stellate ganglion block, and the critical intersection of sleep apnea with surgical outcomes and pediatric obesity. These articles highlight the multidisciplinary nature of modern sleep medicine, integrating neuroscience, pharmacology, and clinical practice.

Together, these contributions advance our understanding of sleep disorder pathophysiology while providing evidence-based insights into treatment optimization. The issue underscores the importance of individualized therapeutic approaches and the need for continued research into both pharmacological and non-pharmacological interventions in sleep medicine.